BML, Inc. (4694.T)

2,908.00 0.00 (0.00%) At close: 03:15PM JST

BML, Inc.

5-21-3 Sendagaya
Shibuya-ku
Tokyo 151-0051
Japan
81 3 3350 0111
https://www.bml.co.jp

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 4,415

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Kensuke Kondo	President & Representative Director	N/A	N/A	1966
Mr. Norihisa Takebe	SMEO, GM of Corp Planning Dept, Sales Mgmt Dept, Acc Dept and Affiliated Business Dept & Director	N/A	N/A	1962
Mr. Nobuki Arai	Executive VP & Representative Director	N/A	N/A	1960
Hideaki Osawa	Director & Executive Officer	N/A	N/A	1964
Masami Kondo	Managing Executive Officer	N/A	N/A	N/A
Mr. Kenji Shibata	Executive Officer & Director	N/A	N/A	1959
Hiroyuki Kigoshi	Managing Executive Officer	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.

Description

BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures. It also provides medical information system services, which include electronic medical charts for networking medical information, as well as preventive medicine services. In addition, the company offers food sanitation test, including food sanitation control and food processing services, which comprise contract services for microorganism testing of raw materials, and prepared and processed food; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and wastewater tests; work environment services, such as measurement of ethylene oxide gas, formaldehyde, organic solvent, and dust; environmental monitoring, which include measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; human genome analysis services; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.

Corporate governance

BML, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.